Page 10 - Development Highlights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Accesswire. The AP news staff was not involved in its creation. Relief Reports 2020 Financial Results and Provides Business Update April 15, 2021 GMT GENEVA, SWITZERLAND / ACCESSWIRE / April 15, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (“Relief” or the “Company”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat COVID-19 induced lung injury, today announced its 2020 financial results for the year ended December 31, 2020 and provided a business update. “The past year has b...

Relief Therapeutics Holding AG: Relief Reports 2020 Financial Results and Provides Business Update Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat COVID-19 induced lung injury, today announced its 2020 financial results for the year ended December 31, 2020 and provided a business update. "The past year has been an incredibly productive and rewarding one for all of us at Relief," said Raghuram (Ram) Selvaraju, Chairman of the Board. "We have had an opportunity to make a true difference in fighting ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. PAE Reports Fourth-Quarter and Full Year 2020 Financial Results PAEMarch 11, 2021 GMT Fourth-quarter operating income of $20.5 million; $90.8 million for the year Fourth-quarter net loss of $6.1 million; $15.3 million net income for the year Fourth-quarter adjusted EBITDA1 of $44.0 million (margin of 5.6%1 of revenue); $180.2 million (margin of 6.6% of revenue) for the year Fourth-quarter cash flows provided by operations of $8.7 million; $100.9 million cash flows provided by operations for the year...

(2) TORONTO, ON / ACCESSWIRE / January 14, 2021 / 01 Communique Laboratory Inc. (the "Company") (TSXV:ONE)(OTCQB:OONEF) is pleased to report that the Company made significant developments throughout 2020 to help ensure the successful commercialization of its IronCAP technology and build revenue from its remote access service business. Andrew Cheung, 01 Communique CEO, stated, "We are pleased with our developmental and commercialization progress in 2020 and our new business partnership arrangements that showcase our IronCAP products. Our goal is to offer products with the most advanced and sec...